Recombinant human interferon α2b (Hainan General Union)

重组人干扰素α2b(海南通用同盟)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human interferon α2b (Hainan General Union)
Drug Alias Name干扰素α-2b生物类似药 - 海南通用同盟尤尼隆
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsVirus Diseases
Approved Indications in ChinaVirus Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date2004/04/12
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A